Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Regeneron
Regeneron
Chasing Regeneron, Pfizer posts data on $250M cardiovascular bet
Fierce Biotech
Wed, 11/24/21 - 10:15 am
Pfizer
Regeneron
antisense
clinical trials
vupanorsen
dyslipidemia
Vaccibody gets a new name and loads up with nearly $1B in biobucks for new vaccine pact with Regeneron
Endpoints
Tue, 11/23/21 - 09:51 am
Vaccibody
Nykode Therapeutics
Regeneron
biobucks
cancer
infectious disease
Why Regeneron's Results for Its COVID Antibody Therapy Won't Boost Sales Much
Motley Fool
Sat, 11/20/21 - 12:01 pm
Regeneron
Roche
COVID-19
antibodies
Merck’s Anti-Cholesterol Drug Threatens Esperion, Other PCSK9 Inhibitor Makers
BioSpace
Mon, 11/15/21 - 11:55 pm
Merck
PCSK9 inhibitors
Amgen
Repatha
Esperion
Sanofi
Regeneron
Praluent
Regeneron COVID-19 antibody drug reduces infection risk 82% in clinical trial
Beckers Hospital Review
Mon, 11/8/21 - 11:03 am
Regeneron
COVID-19
antibodies
clinical trials
How Regeneron's Covid Drug Lent Itself To A Big Third-Quarter Beat
Investors Business Daily
Thu, 11/4/21 - 10:41 am
Regeneron
earnings
COVID-19
Sanofi, Regeneron gear up for new Dupixent filing after clearing second PhIII for eosinophilic esophagitis
Endpoints
Mon, 10/25/21 - 10:48 am
Sanofi
Regeneron
Dupixent
eosinophilic esophagitis
clinical trials
Will Merck's COVID-19 Pill Sink Regeneron's and Eli Lilly's Antibody Therapy Sales?
Motley Fool
Fri, 10/22/21 - 12:18 pm
Merck
COVID-19
molnupiravir
Regeneron
Eli Lilly
antibodies
Dupixent scores a first in rare skin disease prurigo nodularis
Pharmaforum
Fri, 10/22/21 - 11:22 am
Sanofi
Regeneron
Dupixent
prurigo nodularis
Regeneron, Novo Nordisk, Lilly and AbbVie stake claims on September's list of top TV ad spenders
Fierce Pharma
Mon, 10/18/21 - 10:49 pm
Regeneron
Novo Nordisk
Eli Lilly
AbbVie
television ads
DTC ads
diabetes
immunology
Regeneron Antibody Cocktail a Priority for FDA with April Action Date
BioSpace
Fri, 10/15/21 - 12:35 pm
Regeneron
FDA
priority review
COVID-19
antibodies
Regeneron Could Have a Big Catalyst Coming in 2022
Motley Fool
Sat, 10/9/21 - 11:11 pm
Regeneron
Libtayo
cervical cancer
FDA
Sanofi
J&J spends $100M upfront, with $1.2B in biobucks, to join Roche and Regeneron in bispecific blood cancer race
Fierce Biotech
Mon, 10/4/21 - 11:08 am
JNJ
Xencor
biobucks
Roche
Regeneron
bispecific antibodies
blood cancers
plamotamab
Regeneron's COVID-19 antibody cocktail reduces hospitalization risk by 71%, study shows
Beckers Hospital Review
Sun, 10/3/21 - 08:39 pm
Regeneron
COVID-19
antibodies
Is the cancer immunotherapy market up for disruption as AstraZeneca, Regeneron-Sanofi, cheaper Chinese offerings line up?
Fierce Pharma
Sun, 10/3/21 - 08:27 pm
cancer
oncology
cancer immunotherapy
Merck
AstraZeneca
Regeneron
Sanofi
ESMO21: Libtayo extends survival in first-line NSCLC, challenging Keytruda
Pharmaforum
Mon, 09/20/21 - 11:07 am
Sanofi
Regeneron
Libtayo
ESMO
non-small cell lung cancer
Merck
Keytruda
Surging US demand triggers new $2.9B purchase of Regeneron's Covid-19 antibodies
Endpoints
Wed, 09/15/21 - 10:47 am
Regeneron
COVID-19
antibodies
government contract
Pfizer's abrocitinib beats blockbuster Dupixent in phase 3 eczema trial, but key questions remain
Fierce Biotech
Mon, 08/30/21 - 11:03 am
Pfizer
abrocitinib
atopic dermatitis
Dupixent
Sanofi
Regeneron
clinical trials
It's back: Eli Lilly's COVID-19 antibody combo makes its return after 2 months on the sidelines
Fierce Pharma
Mon, 08/30/21 - 10:59 am
Eli Lilly
antibodies
COVID-19
Regeneron
GSK
bamlanivimab-etesevimab
Brii gets a Covid-19 antibody boost
EP Vantage
Wed, 08/25/21 - 11:09 am
Brii Biosciences
COVID-19
antibodies
Regeneron
Pages
« first
‹ previous
…
5
6
7
8
9
10
11
12
13
…
next ›
last »